These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
996 related articles for article (PubMed ID: 30794366)
21. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil. Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963 [TBL] [Abstract][Full Text] [Related]
22. Oral minoxidil treatment for hair loss: A review of efficacy and safety. Randolph M; Tosti A J Am Acad Dermatol; 2021 Mar; 84(3):737-746. PubMed ID: 32622136 [TBL] [Abstract][Full Text] [Related]
23. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men. Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348 [TBL] [Abstract][Full Text] [Related]
24. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia. Roberts J; Desai N; McCoy J; Goren A Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771 [TBL] [Abstract][Full Text] [Related]
25. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women. Bruce AJ; Pincelli TP; Heckman MG; Desmond CM; Arthurs JR; Diehl NN; Douglass EJ; Bruce CJ; Shapiro SA Dermatol Surg; 2020 Jun; 46(6):826-832. PubMed ID: 31574029 [TBL] [Abstract][Full Text] [Related]
26. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730 [TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712 [TBL] [Abstract][Full Text] [Related]
29. Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia. Gupta AK; Charrette A Skinmed; 2015; 13(3):185-9. PubMed ID: 26380504 [TBL] [Abstract][Full Text] [Related]
30. Minoxidil: a comprehensive review. Gupta AK; Talukder M; Venkataraman M; Bamimore MA J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872 [TBL] [Abstract][Full Text] [Related]
31. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia. Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377 [No Abstract] [Full Text] [Related]
32. Efficacy and Safety of Minoxidil 5% Foam in Combination With a Botanical Hair Solution in Men With Androgenic Alopecia. Keaney TC; Pham H; von Grote E; Meckfessel MH J Drugs Dermatol; 2016 Apr; 15(4):406-12. PubMed ID: 27050695 [TBL] [Abstract][Full Text] [Related]
33. Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review. Sharma AN; Michelle L; Juhasz M; Muller Ramos P; Atanaskova Mesinkovska N Int J Dermatol; 2020 Aug; 59(8):1013-1019. PubMed ID: 32516434 [TBL] [Abstract][Full Text] [Related]
34. Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil. McCoy J; Goren A; Kovacevic M; Shapiro J J Biol Regul Homeost Agents; 2016; 30(4):1153-1155. PubMed ID: 28078868 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. Tanglertsampan C J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746 [TBL] [Abstract][Full Text] [Related]
36. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients. Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287 [TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. Asilian A; Farmani A; Saber M J Cosmet Dermatol; 2024 Mar; 23(3):949-957. PubMed ID: 38031516 [TBL] [Abstract][Full Text] [Related]
38. A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia. Thuangtong R; Thanomkitti K; Suvanasuthi S J Med Assoc Thai; 2017 Jan; 100(1):70-7. PubMed ID: 29911772 [TBL] [Abstract][Full Text] [Related]
39. Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial. Yu L; Moorthy S; Li X; Peng L; Zhang Z; Shen L; Han Y; Huang X Arch Dermatol Res; 2024 Aug; 316(8):532. PubMed ID: 39154106 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study. Suchonwanit P; Iamsumang W; Rojhirunsakool S Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]